Outreach and Treatment for Depression in the Labor Force

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Harvard Medical School
ClinicalTrials.gov Identifier:
NCT00057590
First received: April 4, 2003
Last updated: May 3, 2013
Last verified: May 2013
  Purpose

This study will assess the effects of depression treatment on employee productivity. This study will also evaluate the impact of depression screening and outreach on employees' receptivity to treatment.


Condition Intervention
Depression
Behavioral: Care manager outreach and monitoring

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Official Title: Outreach and Treatment for Depression in the Labor Force

Further study details as provided by Harvard Medical School:

Estimated Enrollment: 590
Study Start Date: March 2003
Detailed Description:

This study is conducted in three phases. In the first phase, employees from various companies participate in an on-line Health Risk Assessment survey at a secure website. Those who display symptoms of depression participate in a brief telephone interview to confirm the depression diagnosis.

In the second phase, depressed participants are randomly assigned to receive either intervention treatment or usual care for 18 months. The intervention consists of periodic telephone contact with a mental health clinician who provides education regarding depression and its treatment. Participants receiving the intervention are also provided with resources to obtain psychotherapy and/or pharmacotherapy. Those who do not seek treatment are monitored and supported. Participants in the usual care arm are informed of their possible depression and are encouraged to seek professional treatment.

The final phase of the study involves data analysis and dissemination of aggregated results. Surveys and questionnaires are used to assess participants.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Major depressive episode
  • Employed
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00057590

Locations
United States, Massachusetts
Harvard Medical School
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Harvard Medical School
  More Information

No publications provided by Harvard Medical School

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00057590     History of Changes
Other Study ID Numbers: R01 MH61941, R01MH061941, DSIR 82-SEDX
Study First Received: April 4, 2003
Last Updated: May 3, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mental Disorders
Mood Disorders

ClinicalTrials.gov processed this record on October 29, 2014